Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 pharmacokinetics of OPC-1085EL ophthalmic solution in healthy adult males
jRCT2080222439Phase 1
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of Mikeluna in ocular hypertension and Glaucoma (3 arms), sponsored by Otsuka Pharmaceutical Co., Ltd. Primary endpoint: Primary pharmacokinetic endpoints.
02
Drugs
Mikeluna
03
Conditions
ocular hypertensionGlaucoma
Beyond the preview
Go deeper on jRCT2080222439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222439.